Mosaic KRAS Variant as a Cause of Developmental Eye Anomalies in an Individual With EncephaloCranioCutaneous Lipomatosis
Clinical Genetics · 29.10.2026
DOI: 10.1111/cge.70274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 29.10.2026. Verfasst von Karthikah Jeganathan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, Science and Technology (HST), Oxford Brookes University, Oxford, UK. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baillie Gifford, Microphthalmia, Anophthalmia and Coloboma Support (MACS) Charity, National Institute for Health and Care Research (NIHR).
Abstract (Originalsprache)
Mosaic RASopathies are a group of rare developmental disorders arising from post‐zygotic variants in members of the RAS/MAPK signalling pathway and with a cancer predisposition. Their phenotypic manifestations are highly variable and depend on the extent and distribution of tissue involvement. Ocular features typically include epibulbar dermoids, although structural eye anomalies are also less commonly reported. We describe a girl with microphthalmia and coloboma whose extraocular features were suggestive of the mosaic RASopathy, EncephaloCranioCutaneous Lipomatosis (ECCL). Genetic analyses of affected tissues revealed a missense variant in the RAS pathway gene KRAS (p.[Ala146Pro]), located in a recurrent hotspot for mosaic RASopathies. The variant was absent in blood, confirming a tissue‐restricted distribution. The identification of this mosaic KRAS variant genetically confirmed the clinical diagnosis of ECCL and prompted appropriate tumour surveillance. This case highlights mosaic RASopathies as a cause of developmental eye anomalies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health, Science and Technology (HST), Oxford Brookes University, Oxford, UK.
- Nonacus Clinical Services, Quinton Business Park, Quinton, Birmingham, UK.
- West Midlands Regional Genetics Laboratories, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
- Eye Department, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
- Eye Department, Oxford University Hospitals, Oxford, UK.
- Radiology Department, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
ORCID-Profile: Karthikah Jeganathan, Fabiola Ceroni, Lidiya V Talbot, Nicola K Ragge
Förderung
- Baillie Gifford
- Microphthalmia, Anophthalmia and Coloboma Support (MACS) Charity
- National Institute for Health and Care Research (NIHR)
- Vinchel Foundation
Zitieren
APA
Jeganathan, K., Ceroni, F., Clokie, S. J. H., Motton Hill, N., Parulekar, M., Johnson, K., Talbot, L. V., Bax, D. A., & Ragge, N. K. (2026). Mosaic KRAS Variant as a Cause of Developmental Eye Anomalies in an Individual With EncephaloCranioCutaneous Lipomatosis. Clinical Genetics. https://doi.org/10.1111/cge.70274
Vancouver
Jeganathan K, Ceroni F, Clokie SJH, Motton Hill N, Parulekar M, Johnson K, et al. Mosaic KRAS Variant as a Cause of Developmental Eye Anomalies in an Individual With EncephaloCranioCutaneous Lipomatosis. Clinical Genetics. 2026. doi:10.1111/cge.70274
BibTeX
@article{Jeganathan2026,
author = {Jeganathan, Karthikah and Ceroni, Fabiola and Clokie, Samuel J H and Motton Hill, Nicole and Parulekar, Manoj and Johnson, Karl and Talbot, Lidiya V and Bax, Dorine A and Ragge, Nicola K},
title = {Mosaic KRAS Variant as a Cause of Developmental Eye Anomalies in an Individual With EncephaloCranioCutaneous Lipomatosis},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70274}
}
EUVIMED